- Home
- Publications
- Publication Search
- Publication Details
Title
Rifabutin: where do we stand in 2016?
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 7, Pages 1759-1771
Publisher
Oxford University Press (OUP)
Online
2016-03-24
DOI
10.1093/jac/dkw024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA
- (2015) Carlos J. Sanchez et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Outcomes From Treating Tuberculosis With Rifampicin or Rifabutin in HIV-Infected Persons Also Receiving Antiretroviral Therapy
- (2015) Timothy M. Rawson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of Rifampin and Rifabutin on Serum Itraconazole Levels in Patients with Chronic Pulmonary Aspergillosis and Coexisting Nontuberculous Mycobacterial Infection
- (2014) Seong Mi Moon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
- (2014) Richard J. Wallace et al. CHEST
- Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
- (2014) H. Moultrie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2013) Hee Ji Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections
- (2013) C. Magis-Escurra et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST
- (2013) Michael Hombach et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies
- (2013) T. N. Kakuda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety of rifabutin replacing rifampicin in the treatment of tuberculosis: a single-centre retrospective cohort study
- (2013) J.-Y. Chien et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
- (2013) T. Schon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation
- (2013) Matthew D. Hickey et al. LIVER TRANSPLANTATION
- The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
- (2013) Frederick A. Sirgel et al. PLoS One
- The Pharmacokinetics and Pharmacodynamics of PulmonaryMycobacterium aviumComplex Disease Treatment
- (2012) Jakko van Ingen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Update on rifampin, rifabutin, and rifapentine drug interactions
- (2012) Anne M. Baciewicz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparison of Serum and Bronchoalveolar Lavage Galactomannan in Diagnosing Invasive Aspergillosis in Solid-Organ Transplant Recipients
- (2012) Payam Tabarsi et al. Experimental and Clinical Transplantation
- Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin
- (2012) Kelly E. Dooley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis
- (2012) Kyung-Wook Jo et al. RESPIRATORY MEDICINE
- Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis
- (2012) Sandrine Lefeuvre et al. TRANSPLANT INTERNATIONAL
- Rifampicin reduces methadone concentrations
- (2012) M. J. Dedicoat BMJ-British Medical Journal
- Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
- (2011) Maria C. Kjellsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency
- (2011) Blandine Rammaert et al. BMC INFECTIOUS DISEASES
- Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir
- (2011) Srinivasan Ramanathan et al. CLINICAL PHARMACOKINETICS
- Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients
- (2011) Elinore F. McCance-Katz et al. DRUG AND ALCOHOL DEPENDENCE
- Experience with rifabutin replacing rifampin in the treatment of tuberculosis
- (2011) D.J. Horne et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge [Short communication]
- (2011) J. van Ingen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro
- (2011) Sumandeep K. Gill et al. TUBERCULOSIS
- Pharmacokinetics of Darunavir/Ritonavir and Rifabutin Coadministered in HIV-Negative Healthy Volunteers
- (2010) V. Sekar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifampin and Posaconazole Coadministration Leads to Decreased Serum Posaconazole Concentrations
- (2010) Carina Hohmann et al. CLINICAL INFECTIOUS DISEASES
- Rifampin Combination Therapy for Nonmycobacterial Infections
- (2010) G. N. Forrest et al. CLINICAL MICROBIOLOGY REVIEWS
- Persistent Corneal Endothelial Deposits Associated with Rifabutin Therapy for Crohnʼs Disease
- (2010) Katie Williams et al. CORNEA
- Update on Rifampin and Rifabutin Drug Interactions
- (2009) Anne M. Baciewicz et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Acute Generalized Exanthematous Pustulosis Caused by Rifabutin
- (2009) Chih-Pin Chen et al. ARCHIVES OF DERMATOLOGY
- Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin
- (2009) Anna Zaczek et al. BMC MICROBIOLOGY
- In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
- (2009) Jakko van Ingen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mycobacterium genavenseduodenitis following allogeneic peripheral blood stem cell transplantation
- (2009) K.J. Lu et al. Transplant Infectious Disease
- Interaction Studies of Tipranavir-Ritonavir with Clarithromycin, Fluconazole, and Rifabutin in Healthy Volunteers
- (2008) C. J. L. la Porte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Concomitant Use of Voriconazole and Rifabutin in a Patient with Multiple Infections
- (2008) Joshua N Schwiesow et al. PHARMACOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started